Rick Simpson Oil (RSO) in Wrangell, Alaska: The Complete Guide by OilWell Cannabis

Living in Wrangell means understanding isolation—not just the geographic kind that comes with being on an island in Southeast Alaska, but the isolation of chronic pain that keeps you from hauling in your salmon catch, the isolation of sleepless winter nights when darkness settles at 3 PM, and the isolation of watching a loved one suffer when the Wrangell Medical Center has done all it can and you’re facing medevac to Juneau or Seattle. We’ve built our entire company around one simple truth: people in remote communities like yours deserve the same access to thoughtful, evidence-based cannabinoid medicine as anyone in Houston or Los Angeles.

This guide is for the longliners with wrecked shoulders, the cannery workers with carpal tunnel so severe they can’t hold a cup of coffee, the caregivers watching someone battle cancer far from MD Anderson’s world-class facilities, and the veterans and fishing families dealing with the invisible wounds of trauma and economic uncertainty. It’s also for the simply curious—those who’ve heard whispers about “RSO” at the harbor or seen discussions in Wrangell’s Facebook groups and want honest information without hype.

ABOUT RICK SIMPSON AND TRADITIONAL RICK SIMPSON OIL

Who is Rick Simpson

Rick Simpson wasn’t a doctor, scientist, or medical researcher—he was a power engineer from Nova Scotia, a blue-collar tradesman whose journey into cannabis medicine began when conventional medicine failed him catastrophically. In 1997, while working at a hospital in Moncton, Simpson fell from scaffolding and suffered a severe head injury. The aftermath—persistent tinnitus, dizziness, post-concussion symptoms—was treated with medications that either didn’t work or made things worse. When cannabis provided relief and his doctor refused to consider it, Simpson’s distrust of the medical system became a conviction that would change the cannabis world.

The pivotal moment came in 2003. After learning about a 1974 NIH-funded study where THC reportedly slowed tumor growth in mice (a finding never replicated in human trials), Simpson applied concentrated cannabis oil to three bumps on his arm that his doctor had diagnosed as basal cell carcinoma. By his account, the lesions disappeared in four days. No independent medical verification exists—no biopsy, no clinical documentation, no peer-reviewed study. But this personal testimony became the origin story of Rick Simpson Oil, a catalyst for a global movement that eventually reached even remote Alaskan communities like Wrangell .

Important context: Simpson’s story is presented here as personal testimony, not medical evidence. It’s historically significant because it sparked worldwide interest in concentrated cannabis oil, not because it’s proven science. That distinction matters—especially here in Wrangell, where we know the difference between a story that gives hope and evidence that guides decisions.

The crusade — spreading the oil

After 2003, Simpson committed himself to producing and giving away cannabis oil for free in his community of Maccan, Nova Scotia. He claimed to help people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia—the same conditions that affect Wrangell families every day. His story reached millions through the 2005 documentary Run From The Cure, which became foundational viewing in cannabis communities worldwide, including among Alaska’s underground cannabis networks .

But Simpson’s advocacy brought him into direct conflict with Canadian law. The RCMP raided his property in 2005 and 2009, charging him with cultivation, possession, and trafficking. Eventually, he left Canada for Europe, continuing his advocacy from Croatia and the Netherlands .

The traditional RSO protocol — Simpson’s 60-gram, 90-day regimen

Simpson’s core recommendation was consuming 60 grams of concentrated cannabis oil over approximately 90 days. For someone in Wrangell facing a serious health crisis, this protocol might sound like a lifeline—but understanding its details is critical.

Goal: 60 grams of high-THC oil in roughly 90 days.

Titration schedule: Start with a half-grain-of-rice-sized dose (10-15mg) three times daily. Double the dose every four days until reaching 1 gram per day by weeks 5-12. That final dose delivers approximately 600-900mg of delta-9 THC daily—far exceeding anything studied in controlled settings. For perspective, the FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5 to 20mg per day .

Administration: Simpson recommended sublingual/oral for systemic issues, topical for skin cancers, and acknowledged inhalation only for immediate symptom relief—not as primary treatment.

Critical context for Wrangell residents: This protocol has never been validated in controlled trials. It assumes crude, unstandardized material with unknown potency. The delta-9 THC exposure at peak dosing (600-900mg/day) carries serious risks: severe intoxication, anxiety, panic, tachycardia, hypotension, and cannabis use disorder [1][13][14][15]. For someone in Wrangell with limited access to emergency care, these risks are especially relevant.

What is traditional RSO as a product?

Source material: Single high-THC indica strains, no standardization—every batch different depending on what was available.

Extraction solvent: Naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol—neither food-grade. This poses serious safety risks, especially in remote areas like Wrangell where medical intervention for solvent toxicity would require emergency evacuation.

Appearance: Nearly black, thick, tar-like oil with possible solvent-residual odor.

Cannabinoid profile: Fully decarboxylated, THC-dominant (60-90% estimated), with minor cannabinoids at uncontrolled natural ratios. No lab testing, no Certificate of Analysis—just whatever the plant yielded.

Terpene content: Effectively none. The solvent and heat destroyed volatile terpenes, leaving a cannabinoid-only product.

Standardization: Zero. Every batch varied based on plant genetics, growing conditions, solvent purity, and the maker’s technique. This unpredictability is precisely what modern formulations solve.

Simpson’s claims vs. the evidence record

Simpson claimed RSO could cure cancer and many other diseases. Evaluating these claims requires the same standards we’d apply to any treatment option in Wrangell’s demanding environment.

What Simpson was not: He had no medical training, conducted no clinical trials, published no peer-reviewed research. His evidence was personal experience and testimonials—no controls, no independent verification, no long-term follow-up .

What preclinical literature shows: In vitro and animal studies demonstrate that THC and CBD can induce cancer cell death and slow tumor growth in controlled lab settings . These findings are scientifically interesting but have not translated to proven human cancer cures. The gap between lab results and patient outcomes is vast and well-documented across all oncology research .

Institutional positions: The National Cancer Institute acknowledges cannabinoid anticancer research but does not endorse cannabis as cancer treatment . The FDA has not approved any cannabis plant product for cancer. Health Canada has never approved RSO for cancer. The National Center for Complementary and Integrative Health identifies the strongest evidence for rare epilepsies, chemo nausea, and HIV/AIDS appetite—not cancer cure [1].

What Simpson got right: He drew attention to cannabinoids as serious biomedical research when the world ignored them. He helped create the cultural and political conditions for the legal cannabis industry that exists today. His advocacy was historically significant, even if his medical claims exceeded the evidence .

What he overstated: Encouraging cancer patients to use RSO instead of proven therapies (surgery, radiation, chemo, immunotherapy) carries genuine harm potential. Delayed treatment for treatable cancers is a documented risk in alternative medicine. In Wrangell, where accessing oncology care already requires travel and expense, this risk is magnified.

Why modern RSO has evolved

The term “RSO” is now generic—many products bear little resemblance to Simpson’s original. Simpson himself criticized commercial products that use the RSO name while departing from his method and philosophy .

OilWell’s approach is different. We respect Simpson’s vision of accessibility and patient control, but we’ve evolved the formulation to address the safety and standardization problems that limited traditional RSO. For Wrangell residents who can’t afford to gamble on untested products or travel to dispensaries in Juneau or Anchorage, this evolution matters.

ABOUT OILWELL CANNABIS AND THE OILWELL RSO FORMULA

Our origin story: From McAllen to Montrose, from Bentley to Wrangell

OilWell Cannabis was founded by Colin Valencia in Houston, Texas, but our roots trace back to McAllen—one of the most economically challenged and dangerous border regions in America, just across the river from Reynosa’s cartel violence. Colin grew up in that environment, learning cannabis intimately while operating in shadows most people never see. He watched best friends get killed or imprisoned. He left home at sixteen. He chose cannabis over darker paths because he believed it could be a safer, more beneficial alternative .

But the real origin—the heart of everything we do—begins with a dog named Bentley. Bentley was more than a pet; he was family. When veterinarians told Colin that Bentley’s paralysis meant euthanasia was the only humane option, he refused to accept it. A rescue worker named Jessica asked the question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin learned to create CBD golden paste. The results weren’t a miracle—they were the application of cannabinoid science to a desperate situation: Bentley got up, walked across the room, and brought Colin his ball to play. From paralyzed and facing euthanasia to fetching. Dogs don’t respond to placebo. This was real .

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced—neurodegeneration (CBG neuroprotection, THCa PPARγ), dementia (CBC neurogenesis), glaucoma (THC CB1 agonism), arthritis (multi-pathway anti-inflammatory). Single cannabinoids weren’t enough. Bentley’s life depended on multi-cannabinoid synergy and pharmaceutical precision.

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction, quitting Xanax cold turkey using the same cannabinoid knowledge that saved Bentley. Our Peace Gummies formula—born from midnight experiments during benzo withdrawal—reflects lived experience, not theory. Colin personally uses the vape form for insomnia and severe PTSD. This isn’t corporate marketing; it’s survival turned into science .

ABC13 Houston featured Colin in seven comprehensive news segments from 2019 to 2023, covering everything from Delta-8 legal analysis to COVID community health leadership to criminal justice reform. When a sitting president announced marijuana pardons, ABC13 turned to Colin—who revealed his own cannabis conviction history—to put it in context for Houstonians. That same credibility and authenticity is what we bring to Wrangell .

The OilWell RSO philosophy: Four principles that matter in Wrangell

Our RSO is not traditional Rick Simpson Oil. It’s a formulated, multi-cannabinoid product informed by RSO tradition but deliberately evolved. Four principles define our approach—each one especially relevant to Wrangell’s unique challenges:

1. Accessibility over gatekeeping
No medical card required. Anyone age 21+ can purchase. We ship nationwide—including to Alaska—and internationally. Simpson believed medicine should be accessible; we’ve built a legal framework that makes it possible even in remote communities like Wrangell where dispensaries don’t exist. You don’t need to fly to Anchorage or take the ferry to Juneau. You can order from your home in Wrangell and have professional-grade RSO delivered to your door.

2. Patient-controlled potency
Our sublingual oil contains 1,500mg of THCa in its raw, non-psychoactive form. You decide whether to use it raw for daytime functional relief (zero impairment, perfect for operating a fishing boat or driving the Marine Highway) or decarboxylate it into delta-9 THC for full psychoactive potency at night. This isn’t rhetoric—it’s chemistry that puts control in your hands, whether you’re dealing with chronic pain from deck work or need sleep support during Wrangell’s long winter nights.

3. Open-source formulas
We publish our complete formulas publicly—every cannabinoid, every milligram. If $129.99 for our sublingual oil or $49.99 for our vape cartridge doesn’t fit your budget (and we understand the economic realities of Wrangell’s high cost of living), you can source ingredients and make your own version. Simpson gave his oil away for free and taught people to make it; we sell a professional product and publish the recipe. That DIY ethos resonates with Alaska’s culture of self-reliance .

4. Evidence-informed, not evidence-overstating
This entire document represents our commitment to honest education about what science actually says. We distinguish between well-supported claims (CBD for seizures), emerging research (CBG for neuroprotection), and overstated marketing (CBN as a proven sleep cure). In Wrangell, where misinformation can spread quickly through isolated communities, this honesty is critical.

Farm Bill compliance and the THCa legal framework for Alaska

The 2018 Farm Bill legalized hemp-derived products containing less than 0.3% delta-9 THC at the federal level. Our RSO Sublingual Oil contains only 90mg of delta-9 THC in the entire 30mL bottle—3mg per mL—well under the threshold. All cannabinoids are hemp-derived, making the product federally legal.

For Wrangell residents, this matters enormously: Alaska legalized recreational cannabis in 2014, but Wrangell has no licensed dispensaries. Our Farm Bill-compliant status means we can legally ship to your Wrangell address without requiring a medical card. You receive a product that’s lab-tested, standardized, and professionally manufactured—not the unpredictable, solvent-extracted oil of the traditional RSO era.

The THCa distinction is crucial. THCa is the acidic, non-psychoactive precursor to delta-9 THC. At the point of sale, it’s Farm Bill compliant because it isn’t THC. When you heat it at 260°F for 45-60 minutes, 1,500mg of THCa converts to approximately 1,315mg of delta-9 THC. Combined with the existing 90mg delta-9 THC, you get ~1,405mg total delta-9 THC—psychoactive potency comparable to traditional illegal RSO, entirely at your discretion.

Important legal notice for Alaska: THCa converts to delta-9 THC when heated. You are responsible for understanding Alaska state and local laws regarding cannabinoid products. We ship with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal responsibility.

Solvent-free production that Wrangell can trust

Traditional RSO production used dangerous solvents like naphtha or isopropyl alcohol—neither food-grade, both carrying contamination risks that are especially concerning in remote areas where medical intervention requires evacuation. Our RSO is not an extraction product; it’s a formulated blend of individual cannabinoid distillates combined at specific ratios in a controlled environment.

We use organic MCT oil as the carrier—food-grade, neutral-tasting, and stable in Wrangell’s variable temperatures. Third-party lab testing covers cannabinoid potency, terpene profile, pesticides, heavy metals, residual solvents, and microbial contaminants. COAs are available on request. When you’re in Wrangell, hundreds of miles from the nearest major medical center, this quality assurance isn’t a luxury—it’s a necessity.

Two product formats for Wrangell’s diverse needs

RSO Sublingual Oil — $129.99

• 30mL bottle (1 fl oz)
• 16,590mg total cannabinoids (553mg/mL)
• Seven cannabinoids: CBD 4,500mg, CBG 3,000mg, delta-8 THC 6,000mg, THCa 1,500mg, delta-9 THC 90mg, CBN 750mg, CBC 750mg
• Live terpenes at 5%
• Onset: 15-45 minutes (sublingual absorption)
• Duration: 4-6 hours
• Approximately 40-60 doses per bottle

Perfect for: Sustained relief during long fishing seasons, managing chronic pain through winter, sleep support during dark nights, daytime functional use without impairment (raw THCa option).

RSO Vape Cartridge — $49.99

• 1-gram cartridge
• 900mg+ total cannabinoids
• Same six-cannabinoid ratio (THCa auto-decarbs at vaping temp)
• Live terpenes at 5%+
• Onset: 1-2 minutes (fastest delivery)
• Duration: 2-4 hours

Perfect for: Breakthrough pain on the boat, acute anxiety in isolated situations, nausea during rough seas, immediate PTSD relief.

When to use each format in Wrangell

Condition-specific usage for Wrangell residents

Important disclaimer: These contexts are informed by cannabinoid research, not medical prescriptions. Our products are not FDA-approved to diagnose, treat, cure, or prevent disease. Always consult your healthcare provider, especially given Wrangell’s limited local medical resources. Do not operate boats, vehicles, or machinery while impaired.

Chemotherapy-related nausea and appetite support
For Wrangell residents traveling to Juneau, Anchorage, or Seattle for cancer treatment, our formula offers support during chemo: 0.5-1.0mL sublingual 1 hour before treatment, with vape puffs for breakthrough nausea. The delta-8 THC antiemetic evidence [9] and delta-9 THC nausea data [1][13] provide the foundation.

Chronic pain (fishing injuries, arthritis, fibromyalgia)
Daytime: 0.3-0.5mL raw sublingual for anti-inflammatory benefits without impairment—critical when you’re operating a fishing vessel or driving the Marine Highway. Nighttime: 0.5-1.0mL decarbed sublingual plus vape for breakthrough pain. The multi-cannabinoid approach targets pathways that single-compound products miss [24].

Sleep support during Wrangell’s long winters
The darkness from October through February disrupts circadian rhythms. 1.0-2.0mL sublingual before bed delivers 25-50mg CBN—the dosage range investigated in recent sleep literature [16][17]. Combined with the full cannabinoid profile, this supports sleep architecture when the sun barely rises.

Anxiety and stress
Rural isolation, economic uncertainty, and seasonal work patterns create unique stress. Daytime: 0.3mL raw sublingual provides CBD and CBG anxiolytic pathways [3][7][8] without psychoactivity. Nighttime: 1.0mL sublingual for full-spectrum support.

General titration principle: Start low, go slow. Begin with 0.25-0.5mL and assess effects over 2-3 hours. Individual responses vary by body weight, metabolism, tolerance, and concurrent medications.

MEDIA RECOGNITION: Why ABC13 Houston’s trust matters for Wrangell

Between 2019 and 2023, ABC13 Houston (KTRK) featured Colin Valencia and OilWell Cannabis in seven distinct news segments. Five different reporters sought us out across those years. No other Houston cannabis operator has that frequency or breadth of coverage.

Why does this matter for Wrangell? Because mainstream media validation from America’s fourth-largest city demonstrates credibility that transcends geography. When you’re ordering a product online to a remote Alaska address, you need to know the company behind it has been independently vetted—not just by us, but by professional journalists who’ve scrutinized our claims, our business practices, and our community impact.

Our media record shows:

Consistency across years — Through every legal shift (Delta-8 boom and bust, Biden pardons, Texas legislative debates), ABC13 returned to Colin as their primary expert source. That consistency builds trust.

Community action — We gave away $35,000 in product to encourage COVID vaccination, coordinated with Houston city government, and proactively removed Delta-8 products before enforcement—acting ethically when it cost us real revenue. That’s the character you’re supporting when you choose OilWell .

Personal stakes — The October 2022 feature revealed Colin’s own marijuana conviction history. This isn’t an outsider corporation; it’s someone who lived the consequences and built a legal business with integrity .

Evidence-based messaging — Every quote aligns with what you read here. Colin’s 2019 statement remains our north star: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

GENERAL KNOWLEDGE: The science behind what we sell

Research method and evidence weighting

We prioritize evidence in this order: human clinical trials, systematic reviews, NIH institutional summaries, then preclinical literature. This hierarchy matters because the evidence base is uneven. CBD and delta-9 THC have the strongest human data; other compounds rely more on reviews, animal studies, and pharmacology [1]-[29].

Institutional baseline from NIH

The National Center for Complementary and Integrative Health states the strongest established cannabinoid evidence is for:

• Rare epilepsies (purified CBD)
• Chemotherapy-related nausea/vomiting (THC-containing medicines)
• HIV/AIDS-related appetite and weight loss

Safety concerns highlighted by NIH include impairment, motor vehicle crash risk, cannabis use disorder, pregnancy complications, contamination, and labeling inaccuracy [1].

Cannabinoid profiles

CBD — Strongest human evidence in our formula. Purified CBD is proven for certain seizure disorders [1][2]. Anxiety research shows promise but limited clinical samples [3]. Pain literature is promising but heterogeneous [4]. Sleep research remains methodologically weak [5]. Liver enzyme elevation is a real concern, especially with concentrated oral products [6]. Bottom line: Most evidence-developed nonintoxicating cannabinoid, but even here, strong evidence is concentrated in specific indications, not broad wellness claims.

CBG — Mostly review and preclinical; human evidence sparse [7][8]. Pharmacologically interesting but not clinically established. Review literature notes it’s being sold commercially while evidence remains thin [7]. Bottom line: Promising minor cannabinoid, not proven therapeutic.

Delta-8 THC — Pharmacologically relevant and psychoactive, much less clinically characterized than delta-9 [9]-[11]. 2022 review found similar pharmacokinetics to delta-9 but weaker CB1 affinity [9]. 2023 public-health review noted adverse consequences and manufacturing concerns [10]. Bottom line: Psychoactive THC analogue with incomplete safety characterization.

THCa — Important chemically but low on direct human therapeutic evidence [12]. Non-psychoactive unless decarboxylated by heat. In vitro and rodent literature suggest anti-inflammatory and neuroprotective possibilities, but not established human outcomes [12]. Bottom line: Relevant precursor whose interpretation depends on processing.

Delta-9 THC — Strongest psychoactive cannabinoid evidence, but clearest adverse-effect burden [1][13]-[15]. NCCIH identifies relevance to chemo nausea, HIV appetite, some pain/MS symptoms [1]. 2022 pain review found short-term benefit but increased dizziness, sedation, nausea, and discontinuation [13]. 2025 high-concentration THC review found consistent unfavorable associations with psychosis and cannabis use disorder [15]. Bottom line: Legitimate therapeutic relevance with significant safety liabilities.

CBN — Weak human evidence; marketing ahead of data [16][17]. 2021 sleep review found no clinical trials using validated measures [16]. 2024 cannabis/sleep review concluded research doesn’t match real-world use scale [17]. Bottom line: Cultural reputation stronger than clinical evidence.

CBC — Emerging, intriguing, overwhelmingly preclinical [18][19]. 2024 review argues distinct pharmacodynamics and highlights antinociceptive, antibacterial, anti-seizure potential [18]. Bottom line: Scientifically credible but clinically immature.

Terpene profiles

Terpene claims need stricter interpretation than cannabinoids. Much literature comes from isolated compounds, essential oils, or preclinical models. Robust proof of entourage effects in humans remains limited [20][29].

Limonene — Review/preclinical focus [20]-[22]. 2021 review described antioxidant, anti-inflammatory, cardioprotective possibilities, but mostly non-human data [21]. Oxidation products are contact allergens [22]. Bottom line: Biologically active but cannabis-specific claims should be conservative.

Myrcene — Mostly preclinical, very limited human evidence [20][23]. Anxiolytic and analgesic properties discussed but human studies lacking [23]. Bottom line: Plausible bioactivity, but sedative claims exceed current proof.

Caryophyllene — Most mechanistically interesting terpene due to CB2 receptor agonism [24]. Anti-inflammatory, neuroprotective, gastroprotective discussed, but human clinical confirmation limited [24]. Bottom line: Strongest candidate for cannabinoid-system significance, but not clinically proven.

Pinene — Promising preclinical, weak human confirmation [20][25]. Brain-health review found signals justifying future study but emphasized lack of robust trials [25]. Bottom line: Deserves attention, but cognition claims are exploratory.

Linalool — Substantial preclinical interest, limited clinical confirmation [20][22][25][26]. Stress/mood pharmacology discussed but lacks robust human trials [26]. Oxidized linalool is a recognized allergen [22]. Bottom line: Credible bioactive terpene but supports cautious phrasing only.

Humulene — Translationally interesting but early [20][27]. 2024 scoping review found broad preclinical anti-inflammatory evidence and some rodent cannabimimetic properties [27]. Bottom line: Valuable for hypothesis generation, not clinical settlement.

Terpinolene — Least clinically characterized [20][28]. 2021 systematic review concluded evidence dominated by in silico, in vitro, animal studies [28]. Bottom line: Biologically interesting but especially underdeveloped clinically.

Research limits and common overstatements

Key takeaways for our formulas:

• Evidence is highly uneven—CBD and delta-9 THC most developed
• Extract/molecule/synthetic/terpene data aren’t interchangeable
• Minor cannabinoids are commercially interesting because underexplored
• Product quality matters as much as molecule identity
• THCa chemistry changes with storage/heating

Overstatements to avoid:

• CBN is not a clinically proven sleep cannabinoid [16][17]
• Myrcene is not a proven human sedative [23]
• Terpenes don’t have proven entourage effects in patients [20][29]
• THCa isn’t always nonpsychoactive—it converts with heat [12]
• Delta-8 THC isn’t safe because it’s hemp-derived—it’s psychoactive with incomplete safety data [9]-[11]

RSO SUBLINGUAL OIL FORMULA: Complete transparency

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30mL bottle with graduated dropper (0.1mL increments)
• Active per mL: 553mg cannabinoids
• Onset: 15-45 minutes
• Duration: 4-6 hours
• Doses per bottle: 40-60 depending on serving size

For Wrangell residents: This is either a purchase decision tool or a DIY recipe. If you source distillates, you can replicate this formula yourself. If you order from us, you’re getting exactly what’s listed—lab-verified, professionally blended, shipped to your door.

RSO VAPE CARTRIDGE FORMULA: Fast relief option

• Live Terpenes: 5%+
• Format: 1 Gram cartridge (510-thread)
• Total cannabinoids: 900mg+
• Onset: 1-2 minutes
• Duration: 2-4 hours
• Feature: Auto-decarboxylation at vaping temperature (400-450°F)

For Wrangell’s maritime environment: The vape format’s 1-2 minute onset is invaluable for acute situations—sudden nausea on rough seas, breakthrough pain during a long haul, panic attacks in isolation. The cartridge is compact and discreet, compatible with standard 510-thread batteries available online.

TERPENE PROFILE (Both Products)

Our seven-terpene blend is identical in both formats:

• Limonene (citrus-bright) — potential mood support
• Myrcene — relaxation properties (note: human evidence limited)
• Caryophyllene (β-caryophyllene) — CB2 agonist, anti-inflammatory potential [24]
• Pinene (forest-fresh) — clarity and respiratory feel
• Linalool (floral, lavender) — calm and stress relief
• Humulene (earthy, woody) — inflammation modulation
• Terpinolene (piney, fruity) — complexity and aroma

For Wrangell: These terpenes connect to Alaska’s natural environment—the spruce and cedar forests, the citrus brightness that is rare in winter, the earthy scents of the Tongass. The sensory experience is part of the therapeutic profile.

GETTING OILWELL RSO TO WRANGELL

We understand geography. While we offer same-day delivery in Houston’s Texas Medical Center (free) and Inner Loop ($5), we know Wrangell requires a different approach.

Nationwide shipping to Alaska

• USPS Priority Mail: 2-3 business days to Anchorage, then forwarded via Alaska’s postal system to Wrangell
• FedEx/UPS Ground: 3-5 business days
• Discreet packaging—no cannabis branding visible
• Temperature-stable packaging for Southeast Alaska’s variable climate
• Full COAs and documentation included for customs/legal clarity

Realistic expectations for Wrangell:

• Plan for 5-7 business days from order to arrival
• Tracking provided—monitor your package’s journey through Alaska’s distribution network
• Signature-required option available for security
• We ship to PO boxes and physical addresses

International shipping note: While Wrangell is in the U.S., our international capabilities demonstrate our experience navigating complex regulatory environments—experience that informs how we handle Alaska’s unique shipping challenges.

Contact us:

• Phone: (832) 416-2816
• Email: [email protected]
• Website: https://oilwellcbd.com/

Business hours (Central Time, plan accordingly for Alaska):

• Monday-Thursday: 10 AM – 7 PM CT
• Friday-Saturday: 10 AM – 10 PM CT
• Sunday: 10 AM – 4 PM CT

FINAL THOUGHTS FOR WRANGELL

Living in the City and Borough of Wrangell means facing challenges most Americans never experience: geographic isolation, extreme weather, limited medical access, and an economy tied to the ocean’s whims. It also means being part of a community that looks out for each other, values self-reliance, and understands that sometimes you have to find your own solutions.

OilWell Cannabis was built from that same ethos. We started not in a boardroom but in a moment of desperation to save a family member. We grew through personal battles with PTSD and pharmaceutical dependence. We’ve been raided, convicted, and marginalized—and we’ve responded by building a company that refuses to sell snake oil, that publishes its formulas, that gives away $35,000 in product to help people get vaccinated, and that warns competitors when they’re accidentally shipping Schedule I narcotics.

We don’t have a physical storefront in Wrangell. But we have something more important: integrity you can verify, formulas you can trust, and a commitment that when you order from us, you’re getting the same product we’d give our own family members.

From our home in Houston to your home in Wrangell—across 3,000 miles of distance but connected by a shared understanding that medicine should be accessible, that patients should control their own treatment, and that honesty matters more than hype—we’re here to provide the best possible version of RSO so you can give it a fair shot and decide if it’s right for you.

Always consult your healthcare provider before using cannabinoid products. Keep out of reach of children. This product has not been evaluated by the Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Do not operate vessels, vehicles, or machinery while under the influence of psychoactive cannabinoids.